2019
Sucessfully Passed USFDA Inspection Without any 483 Observations
COMPANY OVERVIEW
Anuh Pharma Ltd., a Bulk Drugs Manufacturing Company is part of the INR 8.5 bn SK Group of Companies, which employs 2000+ people across businesses such as Manufacturing of API's, Pharma Formulations, Distribution and Logistics.
Established in 1960, Anuh Pharma Ltd. today is one of the largest manufacturers of Macrolides and Anti-TB products in India, besides being a major player in Anti-Bacterials, Anti-Malarial, and Corticosteroids.
Anuh Pharma Ltd. continues to grow everyday thanks to the confidence our clients, employees and shareholders have in us. .
TIMELINE HISTORY
2019
Sucessfully Passed EDQM, Eu-GMP and WHO - PQ Joint Inspection
2019
Innaugrated New Expansion with a Additional Capacity of 900 MTPA for 20 Different Products
2017
Received Consent to Establish for Additional Capacity of 2000 MTPA for 20 Different Products
2016
Renewal of Eu-GMP & CEP for Erythromycin, Erythromycin Ethyl Succinate & Pyrazinamide
2015
Received WHO - PQ for Sulfadoxine
2014
Approval from COFEPRIS - Mexico for Erythromycin Estolate, Erythromycin Stearate, Erythromycin Ethyl Succinate
2013
Renewal of Eu-GMP & CEP for Erythromycin, Erythromycin Ethyl Succinate & Pyrazinamide
2012
Received WHO - PQ for Pyrazinamide & Acquired R&D Assets in Mahape, Navi Mumbai & got DSIR Approval
2010
Received Eu-GMP & CEP for Erythromycin, Erythromycin Ethyl Succinate & Pyrazinamide
2006
Doubled Capacity to 600 MTPA
1995
Doubled Capacity to 300 MTPA
1989
Commenced Manufacturing of Erythromycin Salts with Capacity of 150 MTPA
1960
Year of Establishment & Registration on Bombay Stock Exchange
Anuh Pharma Limited is a Public Limited Company Listed on the Bombay Stock Exchange. The Company is a part of the SK Group.
© 2017 Anuh Pharma Ltd. - All Rights Reserved. Please Read The Disclaimer.